AChRα7 inhibitors belong to a specific chemical class of compounds designed to target and inhibit the activity of the α7 subunit of the nicotinic acetylcholine receptor (AChRα7). The AChRα7 receptor is a ligand-gated ion channel found in the central nervous system, and it plays a significant role in neuronal communication and synaptic transmission. Activation of AChRα7 receptors by acetylcholine or other ligands leads to the opening of ion channels, resulting in the flow of ions across the cell membrane and influencing neuronal excitability.
AChRα7 inhibitors work by specifically targeting the AChRα7 subunit, interfering with its ability to bind acetylcholine or other agonists, and subsequently preventing ion channel opening. By doing so, these inhibitors may modulate the function of AChRα7 receptors and impact the overall neuronal signaling and synaptic transmission. Research into AChRα7 inhibitors is ongoing to uncover their precise mechanisms of action and explore their implications in understanding the intricacies of neuronal communication. The study of AChRα7 inhibitors contributes to a deeper understanding of the complex mechanisms underlying neuronal excitability and synaptic function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NS 1738 | 501684-93-1 | sc-204136 sc-204136A | 10 mg 50 mg | $149.00 $620.00 | 1 | |
Acts as a partial agonist and positive allosteric modulator of α7 nAChR, potentially enhancing cognitive function and showing promise for cognitive impairments. | ||||||
R-(+)-Baclofen (free base) | 69308-37-8 | sc-203228 sc-203228A | 10 mg 50 mg | $50.00 $195.00 | ||
Acts as a GABAB receptor agonist, indirectly modulating α7 nAChR function and studied for cognitive deficits and behavioral abnormalities in fragile X syndrome. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Acts as a positive allosteric modulator of α7 nAChR, enhancing receptor function and potentially improving cognitive deficits in neurodevelopmental and neurodegenerative disorders. | ||||||